These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 32458489)
1. Flavonoids with Vicinal Hydroxyl Groups Inhibit Human Calcitonin Amyloid Formation. Lantz R; Busbee B; Wojcikiewicz EP; Du D Chemistry; 2020 Oct; 26(57):13063-13071. PubMed ID: 32458489 [TBL] [Abstract][Full Text] [Related]
2. Effects of disulfide bond and cholesterol derivatives on human calcitonin amyloid formation. Lantz R; Busbee B; Wojcikiewicz EP; Du D Biopolymers; 2020 May; 111(5):e23343. PubMed ID: 31804717 [TBL] [Abstract][Full Text] [Related]
3. Inhibiting Human Calcitonin Fibril Formation with Its Most Relevant Aggregation-Resistant Analog. Chen YT; Hu KW; Huang BJ; Lai CH; Tu LH J Phys Chem B; 2019 Dec; 123(48):10171-10180. PubMed ID: 31692350 [TBL] [Abstract][Full Text] [Related]
4. Atomistic mechanism of polyphenol amyloid aggregation inhibitors: molecular dynamics study of Curcumin, Exifone, and Myricetin interaction with the segment of tau peptide oligomer. Berhanu WM; Masunov AE J Biomol Struct Dyn; 2015; 33(7):1399-411. PubMed ID: 25093402 [TBL] [Abstract][Full Text] [Related]
5. A comparative study of amyloid fibril formation by residues 15-19 of the human calcitonin hormone: a single beta-sheet model with a small hydrophobic core. Haspel N; Zanuy D; Ma B; Wolfson H; Nussinov R J Mol Biol; 2005 Feb; 345(5):1213-27. PubMed ID: 15644216 [TBL] [Abstract][Full Text] [Related]
6. Role of aromatic residues in amyloid fibril formation of human calcitonin by solid-state 13C NMR and molecular dynamics simulation. Itoh-Watanabe H; Kamihira-Ishijima M; Javkhlantugs N; Inoue R; Itoh Y; Endo H; Tuzi S; Saitô H; Ueda K; Naito A Phys Chem Chem Phys; 2013 Jun; 15(23):8890-901. PubMed ID: 23552643 [TBL] [Abstract][Full Text] [Related]
7. Inhibition by flavonoids of amyloid-like fibril formation by Plasmodium falciparum merozoite surface protein 2. Chandrashekaran IR; Adda CG; MacRaild CA; Anders RF; Norton RS Biochemistry; 2010 Jul; 49(28):5899-908. PubMed ID: 20545323 [TBL] [Abstract][Full Text] [Related]
8. The role of phenolic OH groups of flavonoid compounds with H-bond formation ability to suppress amyloid mature fibrils by destabilizing β-sheet conformation of monomeric Aβ17-42. Andarzi Gargari S; Barzegar A; Tarinejad A PLoS One; 2018; 13(6):e0199541. PubMed ID: 29953467 [TBL] [Abstract][Full Text] [Related]
9. NMR characterization of monomeric and oligomeric conformations of human calcitonin and its interaction with EGCG. Huang R; Vivekanandan S; Brender JR; Abe Y; Naito A; Ramamoorthy A J Mol Biol; 2012 Feb; 416(1):108-20. PubMed ID: 22200484 [TBL] [Abstract][Full Text] [Related]
10. Structural Perturbation of Monomers Determines the Amyloid Aggregation Propensity of Calcitonin Variants. Liu Y; Wang Y; Zhang Y; Zou Y; Wei G; Ding F; Sun Y J Chem Inf Model; 2023 Jan; 63(1):308-320. PubMed ID: 36456917 [TBL] [Abstract][Full Text] [Related]
11. Tyrosine 12 of human calcitonin modulates its amyloid formation, membrane binding, and bioactivity. Hsieh IC; Chen TW; Chuang YP; Lai YJ; Tu LH Biochimie; 2022 Jun; 197():121-129. PubMed ID: 35240220 [TBL] [Abstract][Full Text] [Related]
12. (-)-epigallocatechin-3-gallate (EGCG) maintains kappa-casein in its pre-fibrillar state without redirecting its aggregation pathway. Hudson SA; Ecroyd H; Dehle FC; Musgrave IF; Carver JA J Mol Biol; 2009 Sep; 392(3):689-700. PubMed ID: 19616561 [TBL] [Abstract][Full Text] [Related]
13. Controlling the self-assembly of human calcitonin: a theoretical approach using molecular dynamics simulations. Paul S; Paul S Phys Chem Chem Phys; 2021 Jul; 23(26):14496-14510. PubMed ID: 34184696 [TBL] [Abstract][Full Text] [Related]
14. Computational Study of the Aza-Michael Addition of the Flavonoid (+)-Taxifolin in the Inhibition of β-Amyloid Fibril Aggregation. Ginex T; Trius M; Luque FJ Chemistry; 2018 Apr; 24(22):5813-5824. PubMed ID: 29384229 [TBL] [Abstract][Full Text] [Related]
15. Quinopeptide formation associated with the disruptive effect of epigallocatechin-gallate on lysozyme fibrils. Cao N; Zhang YJ; Feng S; Zeng CM Int J Biol Macromol; 2015; 78():389-95. PubMed ID: 25931397 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of amyloid fibril formation in the variable domain of λ6 light chain mutant Wil caused by the interaction between its unfolded state and epigallocatechin-3-O-gallate. Abe Y; Odawara N; Aeimhirunkailas N; Shibata H; Fujisaki N; Tachibana H; Ueda T Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2570-2578. PubMed ID: 30251653 [TBL] [Abstract][Full Text] [Related]
17. Converting the highly amyloidogenic human calcitonin into a powerful fibril inhibitor by three-dimensional structure homology with a non-amyloidogenic analogue. Andreotti G; Vitale RM; Avidan-Shpalter C; Amodeo P; Gazit E; Motta A J Biol Chem; 2011 Jan; 286(4):2707-18. PubMed ID: 21078667 [TBL] [Abstract][Full Text] [Related]